Cargando…
Long-Term Prostate-Specific Antigen Response on a Low-Dose Cabazitaxel Regimen for Metastatic Castration-Resistant Prostate Cancer: A Case Report
Patient: Male, 71-year-old Final Diagnosis: Castration-resistant prostate cancer Symptoms: None Medication:— Clinical Procedure: Chemotherapy Specialty: Urology OBJECTIVE: Unusual clinical course BACKGROUND: Cabazitaxel is a second-generation taxane approved for patients with metastatic castration-r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8272937/ https://www.ncbi.nlm.nih.gov/pubmed/34219125 http://dx.doi.org/10.12659/AJCR.930989 |